A Study to Assess the Effect of Ticlopidine on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants

NCT03298906 PHASE1 COMPLETED

The purpose of this study is to evaluate the effects of ticlopidine on the pharmacokinetics (PK) of intranasally administered esketamine.

Details

Lead sponsor	Janssen Research & Development, LLC
Phase	PHASE1
Status	COMPLETED
Enrolment	16
Start date	Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Nov 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Healthy

Interventions

• Esketamine
• Ticlopidine

Countries

Belgium